VES001
Asset
Brain-penetrant sortilin ligand
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Proteostasis
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Frontotemporal dementia
Phase 2, vesperbio.com, 10 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors4
- Aging relevance1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.